Another typical day for BDX - a dismal perfofmance on a day when the market in general soared. Doesn't anyone care? Where is the sense of outrage among shareholders? It's painfully obvious that nothing is going to occur internally.There certainly appears to be a do-nothing Board of Directors.By way of contrast,look at Campbell Soups, which only yesterday replaced its CEO.This is not to say Ludwig should suffer the same fate -in all fairness he has not had sufficient time.However,why not put him in complete control by naming him Chairman also(in place of Castellini)? Perhaps then he could demonstrate some boldness and show Wall Street that the Company is serious about improving shareholder value.It is extremely depressing to see the Company barely make its numbers quarter after quarter,indeed year after year. After a little spurt recently to $34 a share,probably based on some biotech hype, the stock has drifted back to around $30.Also,there doesn't seem to be any remote likelihood of a takeover. All in all,a very gloomy scenario -as said at the outset,where is the sense of outrage? IT'S THE SHAREHOLDERS' MONEY !!
The Lincoln, Nebraska Journal Star (www.journalstar.com) ran an AP story on 3/23 announcing a $30 million state tax incentive package for a proposed $146 million plant expansion and creation of 287 new jobs at the BD Columbus plant. The next day, the stock dropped to $28 while the market rose. Makes no sense. The Columbus plant is the flagship mfg. plant for needles and some syringe sizes, and is the location where new products (i.e. safety products) are initially produced. I am a former employee, and a significant part of my retirement account is BD stock. Top management may have made some mistakes, but they have also done a lot to create the demand for the new safety products. Since BD owns the market for syringes and needles, this is the best area for domestic growth. They are clearly interested more in the long term health of the company than in short-term market manipulation. That's just fine with me.
Well BD is back to where it began at $28 per share. The take over BS is over, and now that the smoke has cleared what remains is the same old BD. MR PELLIGRINO WHAT IS GOING ON??? I think that the market will take this stock lower trying to break through $25. At present it is a good short. There is nothing to propel this stock. Management has zero credibility with the Street, and the major income producing product lines continue to age. The financial returns on acquisitions over the last several years have been poor. Much money has been sunk into a plant in China which now is looking like a questionable move. What is there good to talk about? Tell me MR PELLIGRENO I am all ears.